The first FDA-cleared device that supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our five FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without additional equipment, procedures or radiation dose.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
Managing your lung program can seem daunting, whether you’re getting going, growing, or managing workflow. We’ve curated resources for you.
Now, radiologists can achieve newfound Certainty of Search using the ClearRead CT technology, the only Clear Visual Intelligence solution with our unique suppression technology. It removes the vessels and machine noise on the chest CT image, providing an unimpaired view of the chest for efficient and accurate detection of cardiothoracic diseases. ClearRead CT is a natural addition for opportunistic CAC and nodule detection or as part of a lung cancer screening program.
ClearRead CT is now FDA-cleared for nodule detection and quantification of coronary artery calcification (CAC). Read the ClearRead CT CAC announcement here.
Opportunistic CAC screening is now possible with ClearRead CT CAC by leveraging every ungated, non-contrast chest CT for cardiac risk assessment and early intervention. ClearRead CT CAC accurately detects, quantifies and reports an Agatston score. The normalization capabilities lend to high accuracy across CT systems for consistent results, regardless of the equipment used. In a clinical study, ClearRead CT CAC demonstrated high agreement with readers and gated CAC exams for an accurate result on ungated CTs.15
Empower your organization with the CAC scoring tools to prevent patient leakage and help patients stay ahead of coronary artery disease.
Click the arrows to see the CAC report for each case on an ungated chest CT.
ClearRead CT Vessel Suppress produces a secondary series of CT images, suppressing vessels and other normal structures within the lungs to improve conspicuity of all nodule types, including solid, sub-solid and ground glass nodules. The Vessel Suppress series gives users access to a truly unique and patented technology that aids in improved reading accuracy and efficiency. The processed series can be easily linked with the original CT series for synchronized scrolling without the need for a separate application viewer.
ClearRead CT Vessel Suppress provides an unimpaired view that improves diagnostic accuracy, efficiency, and improved nodule characterizations.1 In these comparison videos, the images on the right display the significant ClearRead difference.
ClearRead CT Detect leverages the vessel-suppression series to locate, characterize, and report suspected nodules, enabling transparent, precise automatic measurements. Easily and quickly make informed decisions about regions of interest with automatic detection, segmentation and measurement of nodules. The PACS workflow and PowerScribe integrations make the process seamless.
Riverain’s CT Detect technology provides measurements for each detected region of interest including location, type, volume, maximum, minimum, average axial plane diameters, and nodule depth. Use the navigation arrows above the images to scroll and see the ClearRead difference.
ClearRead CT Compare extends Detect by automatically matching nodules found in a current exam to the same nodule in a prior exam, enabling efficient visual and volumetric comparisons.
For each image in this gallery, you can see the current exam on the left and the prior exam on the right. The image chips at the bottom provide a close-up view of the individual finding, along with extracted measurements. Use the navigation arrows above the images to scroll and see the ClearRead difference.
Our acquisition normalization technology supports rapid installation of software based on elimination of the requirement to tune to specific scanners.
Installation and configuration of our software typically take as little as four hours. The simplicity of the ClearRead installation on site is based on Riverain’s image normalization technology that eliminates the need for tuning to specific manufacturers or imaging protocols. Using the existing PACS review station for image interpretation also simplifies deployment.
Our acquisition normalization technology supports rapid installation of software based on elimination of the requirement to tune to specific scanners.
Installation and configuration of our software typically take as little as four hours. The simplicity of the ClearRead installation on site is based on Riverain’s image normalization technology that eliminates the need for tuning to specific manufacturers or imaging protocols. Using the existing PACS review station for image interpretation also simplifies deployment.
Seamless PACS integration allows readers to view ClearRead as an additional series in the patient study without the need for a separate application viewer to read studies quickly and intuitively for speed and accuracy.
ClearRead CT is FDA approved for concurrent reading, allowing the clinician to view the ClearRead series and the original series simultaneously. The seamless PACS integration makes viewing the ClearRead CT images easy, and the PowerScribe integration is an effortless method of reporting findings.
Seamless PACS integration allows readers to view ClearRead as an additional series in the patient study without the need for a separate application viewer to read studies quickly and intuitively for speed and accuracy.
ClearRead CT is FDA approved for concurrent reading, allowing the clinician to view the ClearRead series and the original series simultaneously. The seamless PACS integration makes viewing the ClearRead CT images easy, and the PowerScribe integration is an effortless method of reporting findings.
ClearRead technology implements the latest artificial intelligence and deep learning technologies for optimized content, workflow, and results.
ClearRead CT technology has surpassed the state-of-the-art by a significant margin based on a combination of frameworks, modeling, and computational ingenuity. While achieving high reliability and significant performance usually depends on substantial amounts of processing, our system can run on commodity hardware, without the need for special computer cards or large memory systems.
ClearRead technology implements the latest artificial intelligence and deep learning technologies for optimized content, workflow, and results.
ClearRead CT technology has surpassed the state-of-the-art by a significant margin based on a combination of frameworks, modeling, and computational ingenuity. While achieving high reliability and significant performance usually depends on substantial amounts of processing, our system can run on commodity hardware, without the need for special computer cards or large memory systems.
Our advanced AI imaging software is used by leading international healthcare organizations and is continually evaluated for its effectiveness.
Ultimately, Riverain understands that the main concern of clinicians when adopting new software is knowing that it is properly verified and validated. Peer reviewed articles; third-party studies and reference accounts are essential to the integrity of our ClearRead AI technology. Our success is supported by ample clinical evidence.
Our advanced AI imaging software is used by leading international healthcare organizations and is continually evaluated for its effectiveness.
Ultimately, Riverain understands that the main concern of clinicians when adopting new software is knowing that it is properly verified and validated. Peer reviewed articles; third-party studies and reference accounts are essential to the integrity of our ClearRead AI technology. Our success is supported by ample clinical evidence.
Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
